D
Inhibikase Therapeutics, Inc. IKT
$2.37 $0.010.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -2.27% 3.40% -7.32% -5.40% -1.67%
Total Depreciation and Amortization -84.98% -84.55% 1,429.91% 2,547.76% 10,241.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -22.35% -18.33% 0.79% 1.26% -35.96%
Change in Net Operating Assets 586.66% 227.62% 231.12% 37.09% 53.06%
Cash from Operations 5.24% 15.97% 17.58% -4.23% -1.72%
Capital Expenditure 100.00% 100.00% 94.16% 94.16% 94.16%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -101.91% 174.47% 165.73% 174.04% 190.47%
Cash from Investing -101.91% 173.64% 164.93% 172.83% 189.35%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- 100.00%
Issuance of Common Stock -55.78% -57.90% -95.36% 19,354.88% 19,353.74%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -57.21% -59.34% -97.75% 4,204.00% 4,271.44%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -253.62% 103.90% 95.09% 105.89% 123.24%
Weiss Ratings